Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks

Obesity Facts

Volumn 4, Issue 4, 2011, Pages 324-328

  Hainerová, Irena Aldhoon ^a   Zamrazilová, Hana ^b   Sedláčková, Dana ^b   Hainer, Vojtěch ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Hypogonatropic hypogonadism; MC4R; Monogenic obesity; Sibutramine treatment

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PROTIRELIN; SEX HORMONE; SIBUTRAMINE; TESTOSTERONE;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; CASE REPORT; CLINICAL EXAMINATION; FOLLITROPIN BLOOD LEVEL; GENE; GENE MUTATION; HEALTH HAZARD; HOMOZYGOSITY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS; LIFESTYLE MODIFICATION; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MC4R GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; PULSE RATE; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT GAIN;

ADULT; APPETITE DEPRESSANTS; BODY COMPOSITION; BODY WEIGHT; CYCLOBUTANES; GONADOTROPINS; HOMOZYGOTE; HUMANS; HYPOGONADISM; MALE; METABOLIC DISEASES; MUTATION; OBESITY; RISK; SEX CHARACTERISTICS; TESTOSTERONE; YOUNG ADULT;

EID: 80053016593     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000330763     Document Type: Article

References (33)

1. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougnères P, Lebouc Y, Froguel P, Guy-Grand B: A Mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401. (Pubitemid 28168737)
2. Farooqi IS: Monogenic human obesity. Front Horm Res 2008;36:1-11.
3. Hebebrand J, Geller F, Dempfle A, Heinzel-Gutenbrunner M, Raab M, Gerber G, Wermter AK, Horro FF, Blundell J, Schafer H, Remschmidt H, Herpetz S, Hinney A: Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations. Mol Psychiatry 2004;9:796-800. (Pubitemid 39107968)
4. Hainerová I, Larsen LH, Holst B, Finková M, Hainer V, Lebl J, Hansen T, Pedersen O: Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response and functional analysis. J Clin Endocrinol Metab 2007;92:3689-3696. (Pubitemid 47435357)
5. Reinehr T, Hebebrand J, Friedel S, Toschke AM, Brumm H, Biebermann H, Hinney A: Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Obesity (Silver Spring) 2009;17:382-389.
6. Aslan IR, Ranadive SA, Ersoy BA, Rogers SJ, Lustig RH, Vaisse C: Bariatric surgery in a patient with complete MC4R deficiency. Int J Obes (Lond) 2011;35:457-461.
7. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C: Weight LOSS after Rouxen-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg 2011;21:930-942.
8. Danielsson P, Janson A, Norgren S, Marcus C: Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab 2007;92:4101-4106. (Pubitemid 350074718)
9. Stunkard A, Messick S: The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83. (Pubitemid 15134378)
10. Devlin MJ, Goldfein JA, Dobrow I: What is this thing called BED? Current status on binge eating nosology. Int J Eat Disord 2003;34(suppl 1):S2-S18. (Pubitemid 36935709)
11. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD: A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-215.
12. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997;16:303-306. (Pubitemid 27280217)
13. Mantzoros CS, Flier JS, Rogol AD: A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997;82:1066-1070. (Pubitemid 27166643)
14. Hadley M: Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides 2005;26:1687-1689. (Pubitemid 41354525)
15. Van der Ploeg LH, Martin WJ, Howard AD, Nargund RP, Austin CP, Guan X, Drisko J, Cashen D, Sebhat I, Patchett AA, Figueroa DJ, DiLella AG, Connolly BM, Weinberg DH, Tan CP, Palyha OC, Pong SS, MacNeil T, Rosenblum C, Vongs A, Tang R, Yu H, Sailer AW, Fong TM, Huang C, Tota MR, Chang RS, Stearns R, Tamvakopoulos C, Christ G, Drazen DL, Spar BD, Nelson RJ, MacIntyre DE: A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A 2002;99:11381-11386. (Pubitemid 34920934)
16. Caquineau C, Leng G, Guan XM, Jiang M, Van der Ploeg L, Douglas AJ: Effects of melanocytestimulating hormone on magnocellular neurones and their activation at intromission in male rats. J Neuroendocrinol 2006;18:685-691. (Pubitemid 44132616)
17. Backholer K, Bowden M, Gamber K, Bjørbaek C, Iqbal J, Clarke IJ: Melanocortins mimic the effects of leptin to restore reproductive function in lean hypogonadotropic ewes. Neuroendocrinology 2010;91:27-40.
18. Arver S, Lehtihet M: Current guidelines for the diagnosis of testosterone deficiency. Front Horm Res 2009;37:5-20.
19. Glass AR, Swerdloff RS, Bray GA, Dahms WT, Atkinson RL: Low serum testosterone and sexhormonebinding globulin in massively obese men. J Clin Endocrinol Metab 1977;45:1211-1219. (Pubitemid 8253447)
20. Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, Rosenfeld RS: Plasma free and nonsexhormone-binding globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 1990;71:929-931.
21. Lima N, Cavaliere H, Knobel M, Halpern A, Medeiros-Neto G: Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. Int J Obes 2000;24:1433-1437.
22. Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF: Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 2000;85:3027-3035.
23. Vermeulen A, Kaufman JM, Deslijpere JP, Thomas G: Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogo nadism of obese men. J Clin Endocrinol Metab 1993;76:1140-1146. (Pubitemid 23155426)
24. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S: Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000;106:271-279. (Pubitemid 30483131)
25. Kobayashi H, Ogawa Y, Shintani M, Ebihara K, Shimodahira M, Iwakura T, Hino M, Ishihara T, Ikekubo K, Kurahachi H, Nakao K: A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 2002;51:243-246. (Pubitemid 34518005)
26. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly: Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348:1085-1095. (Pubitemid 36337319)
27. Lubrano-Berthelier C, Dubern B, Lacorte JM, Picard F, Shapiro A, Zhang S, Bertrais S, Hercberg S, Basdevant A, Clement K, Vaisse C: Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab 2006;91:1811-1818.
28. Barth S, Klein P, Horbach T, Dotchs J, Rauh M, Rascher W, Knerr I: Expression of neuropeptide Y, omentin, and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters. Obes Facts 2010;3:245-251.
29. Sedlackova D, Kopeckova J, Papezova H, Vybiral S, Kvasnickova H, Hill M, Nedvidkova J: Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol Res 2011;60:165-173.
30. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL: Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 2003;289:1805-1812. (Pubitemid 37430250)
31. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O'Rahilly S, Farooqi IS: Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009;360:44-52.
32. Sayk F, Heutling D, Dodt C, Iwen KA, Wellhoner JP, Scherag S, Hinney A, Hebebrand J, Lehnert H: Sympathetic function in human carriers of melanocrotin-4 receptor gene mutations. J Clin Endocrinol Metab 2010;95:1998-2002.
33. Mergen M, Mergen H, Ozata M, Oner R, Oner C: A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001;86:3448-3451. (Pubitemid 32673520)